单位：[1]Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Med Res Ctr, Guangdong Gen Hosp, Guangzhou, Peoples R China广东省人民医院[2]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Peoples R China肿瘤科华中科技大学同济医学院附属同济医院[3]Fourth Mil Med Univ, Tangdu Hosp, Dept Oncol, Xian, Peoples R China[4]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[5]Sichuan Univ, West China Hosp, Dept Thorac Oncol, Ctr Canc, Chengdu, Peoples R China四川大学华西医院[6]Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Peoples R China四川大学华西医院[7]Hubei Canc Hosp, Dept Oncol, Wuhan, Peoples R China[8]Jilin Prov Canc Hosp, Med Oncol, Changchun, Peoples R China[9]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Med Oncol, Beijing, Peoples R China[10]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Pathol, Beijing, Peoples R China[11]Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China四川大学华西医院[12]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
第一作者单位：[1]Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Med Res Ctr, Guangdong Gen Hosp, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang X.,Wu Y-L.,Chen Y.,et al.Dynamic mutation profiles of Chinese patients with EGFR T790M advanced NSCLC receiving osimertinib[J].ANNALS OF ONCOLOGY.2022,33:S1537-S1537.doi:10.1016/j.annonc.2022.10.294.
APA：
Zhang, X.,Wu, Y-L.,Chen, Y.,Zhang, H.,Wu, G....&Liang, Z..(2022).Dynamic mutation profiles of Chinese patients with EGFR T790M advanced NSCLC receiving osimertinib.ANNALS OF ONCOLOGY,33,
MLA：
Zhang, X.,et al."Dynamic mutation profiles of Chinese patients with EGFR T790M advanced NSCLC receiving osimertinib".ANNALS OF ONCOLOGY 33.(2022):S1537-S1537
医学